Author:
Kim Ye-Ryung,Lee Eun-Ji,Shin Kyong-Oh,Kim Min Hee,Pewzner-Jung Yael,Lee Yong-Moon,Park Joo-Won,Futerman Anthony H.,Park Woo-Jae
Abstract
Abstract
The endoplasmic reticulum (ER) is not only important for protein synthesis and folding but is also crucial for lipid synthesis and metabolism. In the current study, we demonstrate an important role of ceramide synthases (CerS) in ER stress and NAFLD progression. Ceramide is important in sphingolipid metabolism, and its acyl chain length is determined by a family of six CerS in mammals. CerS2 generates C22-C24 ceramides, and CerS5 or CerS6 produces C16 ceramide. To gain insight into the role of CerS in NAFLD, we used a high-fat diet (HFD)-induced NAFLD mouse model. Decreased levels of CerS2 and increased levels of CerS6 were observed in the steatotic livers of mice fed a HFD. In vitro experiments with Hep3B cells indicated the protective role of CerS2 and the detrimental role of CerS6 in the ER stress response induced by palmitate treatment. In particular, CerS6 overexpression increased sterol regulatory element-binding protein-1 (SREBP-1) cleavage with decreased levels of INSIG-1, leading to increased lipogenesis. Blocking ER stress abrogated the detrimental effects of CerS6 on palmitate-induced SREBP-1 cleavage. In accordance with the protective role of CerS2 in the palmitate-induced ER stress response, CerS2 knockdown enhanced ER stress and SREBP-1 cleavage, and CerS2 heterozygote livers exhibited a stronger ER stress response and higher triglyceride levels following HFD. Finally, treatment with a low dose of bortezomib increased hepatic CerS2 expression and protected the development of NAFLD following HFD. These results indicate that CerS and its derivatives impact hepatic ER stress and lipogenesis differently and might be therapeutic targets for NAFLD.
Funder
National Research Foundation of Korea
Health Technology R&D Project
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry
Reference60 articles.
1. Lee, J. & Ozcan, U. Unfolded protein response signaling and metabolic diseases. J. Biol. Chem. 289, 1203–1211 (2014).
2. Adams, L. A., Angulo, P. & Lindor, K. D. Nonalcoholic fatty liver disease. CMAJ 172, 899–905 (2005).
3. Pagadala, M., Kasumov, T., McCullough, A. J., Zein, N. N. & Kirwan, J. P. Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol. Metab. 23, 365–371 (2012).
4. McCullough, A. J. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 40(Suppl 1), S17–S29 (2006).
5. Fon Tacer, K. & Rozman, D. Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. J. Lipids 2011, 783976 (2011).
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献